Methods Relating to Peripheral Administration of Nogo Receptor Polypeptides
First Claim
1. A method of increasing the plasma to brain ratio of Aβ
- peptide in a mammal or enhancing Aβ
clearance from the brain of a mammal, comprising administering to a mammal in need thereof a therapeutically effective amount of a soluble Nogo receptor polypeptide, wherein said administration is peripheral to the central nervous system.
0 Assignments
0 Petitions
Accused Products
Abstract
This invention relates to methods of treating diseases involving accumulation of Aβ plaques, including Alzheimer'"'"'s Disease by the peripheral administration of soluble Nogo receptor polypeptides. The invention also provides methods of increasing the plasma to brain ratio of Aβ peptide and enhancing Aβ peptide clearance via peripheral administration of soluble Nogo receptor polypeptides. This invention also provides methods of improving memory function or inhibiting memory loss via the peripheral administration of soluble Nogo receptor polypeptides. The invention also provides methods of decreasing the size and number of Aβ plaques in a mammal via peripheral administration of soluble Nogo receptor polypeptides.
12 Citations
56 Claims
-
1. A method of increasing the plasma to brain ratio of Aβ
- peptide in a mammal or enhancing Aβ
clearance from the brain of a mammal, comprising administering to a mammal in need thereof a therapeutically effective amount of a soluble Nogo receptor polypeptide, wherein said administration is peripheral to the central nervous system. - View Dependent Claims (12, 13, 14, 15, 24, 28, 31, 37, 38, 45, 51, 54, 55, 56)
- peptide in a mammal or enhancing Aβ
-
2. (canceled)
-
3. (canceled)
-
4. A method of reducing the number of Aβ
- plaques or the size of Aβ
plaques in the brain of a mammal, comprising administering to a mammal in need thereof a therapeutically effective amount of a soluble Nogo receptor polypeptide, wherein said administration is peripheral to the central nervous system.
- plaques or the size of Aβ
-
5. (canceled)
-
6. A method of treating a disease associated with Aβ
- plaque accumulation in a mammal comprising administering to a mammal in need thereof a therapeutically effective amount of a soluble Nogo receptor polypeptide, wherein said administration is peripheral to the central nervous system.
- View Dependent Claims (7, 8)
-
9. (canceled)
-
10. (canceled)
-
11. (canceled)
-
16. (canceled)
-
17. (canceled)
-
18. (canceled)
-
19. (canceled)
-
20. (canceled)
-
21. (canceled)
-
22. (canceled)
-
23. (canceled)
-
25. (canceled)
-
26. (canceled)
-
27. (canceled)
-
29. (canceled)
-
30. (canceled)
-
32. (canceled)
-
33. (canceled)
-
34. (canceled)
-
35. (canceled)
-
36. (canceled)
-
39. (canceled)
-
40. (canceled)
-
41. (canceled)
-
42. (canceled)
-
43. (canceled)
-
44. (canceled)
-
46. (canceled)
-
47. (canceled)
-
48. (canceled)
-
49. (canceled)
-
50. (canceled)
-
52. (canceled)
-
53. (canceled)
Specification